Last 12 months
Inside the activity.
1 purchase rows · 61 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 1 | 6 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2019 Filed May 28, 2019 15:17 UTC |
OLIVEIRA RAMON DEDirector
|
GrantCommon Stock | 12,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032944 · doc4.xml · nonDerivative · entry 1 OLIVEIRA RAMON DE · CIK 0001214685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,243 F1 · shares: Grant of fully vested common stock under the AXA Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3. Read SEC document |
| May 23, 2019 Filed May 28, 2019 17:17 UTC |
Stonehill Charles G.T.Director
|
GrantCommon Stock | 7,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032916 · doc4.xml · nonDerivative · entry 1 Stonehill Charles G.T. · CIK 0001739527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,474 F1 · kind: Grant of fully vested common stock under the AXA Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under rule 16b-3. Read SEC document |
| May 23, 2019 Filed May 28, 2019 19:16 UTC |
Kaye Daniel GDirector
|
GrantCommon Stock | 7,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032941 · doc4.xml · nonDerivative · entry 1 Kaye Daniel G · CIK 0001556974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,474 F1 · shares: Grant of fully vested common stock under the AXA Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3. Read SEC document |
| May 23, 2019 Filed May 28, 2019 19:04 UTC |
Matus Kristi AnnDirector
|
GrantCommon Stock | 7,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032939 · doc4.xml · nonDerivative · entry 1 Matus Kristi Ann · CIK 0001543504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,474 F1 · shares: Grant of fully vested common stock under the AXA Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under rule 16b-3. Read SEC document |
| May 10, 2019 Filed Feb 14, 2020 21:15 UTC |
HURD JEFFREY JSenior EVP & COO
|
Tax withholdingCommon Stock | 2,306.98 | $22.20 | $51,214.96 |
DisclosureSEC source: 0001209191-20-009629 · doc5.xml · nonDerivative · entry 6 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,152.6 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| May 10, 2019 Filed Feb 14, 2020 21:15 UTC |
BERNSTEIN SETH PSee Remarks
|
Tax withholdingCommon Stock | 2,507.98 | $22.20 | $55,677.16 |
DisclosureSEC source: 0001209191-20-009630 · doc5.xml · nonDerivative · entry 5 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,689.52 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| May 10, 2019 Filed Feb 14, 2020 21:15 UTC |
Pearson MarkDirector · President and CEO
|
Tax withholdingCommon Stock | 12,536.9 | $22.20 | $278,319.18 |
DisclosureSEC source: 0001209191-20-009633 · doc5.xml · nonDerivative · entry 6 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,563.59 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| May 10, 2019 Filed Feb 14, 2020 21:15 UTC |
Hattem Dave S.SEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 5,014.96 | $22.20 | $111,332.11 |
DisclosureSEC source: 0001209191-20-009631 · doc5.xml · nonDerivative · entry 6 Hattem Dave S. · CIK 0001739394 · SEVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,219.43 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| May 10, 2019 Filed Feb 14, 2020 21:15 UTC |
Malmstrom AndersSenior EVP & CFO
|
Tax withholdingCommon Stock | 5,014.96 | $22.20 | $111,332.11 |
DisclosureSEC source: 0001209191-20-009628 · doc5.xml · nonDerivative · entry 6 Malmstrom Anders · CIK 0001705476 · Senior EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,074.72 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 17:37 UTC |
AXA S.A.10% owner
|
OtherCommon Stock | 30,000,000 | $19.99 | $599,625,000.00 |
DisclosureSEC source: 0001209191-19-021119 · doc4.xml · nonDerivative · entry 2 AXA · CIK 0000898427 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,162,500 F1 · kind: Reflects the concurrent repurchase by AXA Equitable Holdings, Inc. of 30,000,000 shares of its common stock from AXA S.A. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 17:37 UTC |
AXA S.A.10% owner
|
SaleCommon Stock | 46,000,000 | $19.99 | $919,425,000.00 |
DisclosureSEC source: 0001209191-19-021119 · doc4.xml · nonDerivative · entry 1 AXA · CIK 0000898427 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,162,500 Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Eckert William James IVSVP and CAO
|
GrantCommon Stock | 89.33 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009632 · doc5.xml · nonDerivative · entry 2 Eckert William James IV · CIK 0001693205 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,348.54 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
HURD JEFFREY JSenior EVP & COO
|
GrantPerformance Restricted Stock Units · Derivative | 117.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009629 · doc5.xml · derivative · entry 12 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,843.92 Underlying: Common Stock · 117.27 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
HURD JEFFREY JSenior EVP & COO
|
GrantCommon Stock | 296.72 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009629 · doc5.xml · nonDerivative · entry 5 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,459.58 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Lane Nick(See Remarks)
|
GrantPerformance Restricted Stock Units · Derivative | 125.1 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009634 · doc5.xml · derivative · entry 5 Lane Nick · CIK 0001441552 · (See Remarks) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,103.1 Underlying: Common Stock · 125.1 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F3 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F3 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Lane Nick(See Remarks)
|
GrantCommon Stock | 283.83 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009634 · doc5.xml · nonDerivative · entry 1 Lane Nick · CIK 0001441552 · (See Remarks) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,072.84 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
BERNSTEIN SETH PSee Remarks
|
GrantPerformance Restricted Stock Units · Derivative | 117.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009630 · doc5.xml · derivative · entry 11 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,843.92 Underlying: Common Stock · 117.27 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
BERNSTEIN SETH PSee Remarks
|
GrantCommon Stock | 142.18 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009630 · doc5.xml · nonDerivative · entry 4 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,197.5 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Pearson MarkDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 586.34 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009633 · doc5.xml · derivative · entry 12 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,219.61 Underlying: Common Stock · 586.34 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F5 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F5 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Pearson MarkDirector · President and CEO
|
GrantCommon Stock | 940.24 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009633 · doc5.xml · nonDerivative · entry 5 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,100.49 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related RSUs. Dividend equivalents are issued as RSUs, each representing a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Hattem Dave S.SEVP & Chief Legal Officer
|
GrantPerformance Restricted Stock Units · Derivative | 234.53 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009631 · doc5.xml · derivative · entry 12 Hattem Dave S. · CIK 0001739394 · SEVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,687.84 Underlying: Common Stock · 234.53 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Hattem Dave S.SEVP & Chief Legal Officer
|
GrantCommon Stock | 249.54 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009631 · doc5.xml · nonDerivative · entry 5 Hattem Dave S. · CIK 0001739394 · SEVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,234.39 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Malmstrom AndersSenior EVP & CFO
|
GrantPerformance Restricted Stock Units · Derivative | 234.53 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009628 · doc5.xml · derivative · entry 12 Malmstrom Anders · CIK 0001705476 · Senior EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,687.84 Underlying: Common Stock · 234.53 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| March 15, 2019 Filed Feb 14, 2020 21:15 UTC |
Malmstrom AndersSenior EVP & CFO
|
GrantCommon Stock | 340.74 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009628 · doc5.xml · nonDerivative · entry 5 Malmstrom Anders · CIK 0001705476 · Senior EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,089.68 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 01, 2019 Filed Feb 14, 2020 21:15 UTC |
HURD JEFFREY JSenior EVP & COO
|
Tax withholdingCommon Stock | 2,366.77 | $20.20 | $47,808.75 |
DisclosureSEC source: 0001209191-20-009629 · doc5.xml · nonDerivative · entry 4 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,162.87 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 01, 2019 Filed Feb 14, 2020 21:15 UTC |
Pearson MarkDirector · President and CEO
|
Tax withholdingCommon Stock | 5,726.31 | $20.20 | $115,671.46 |
DisclosureSEC source: 0001209191-20-009633 · doc5.xml · nonDerivative · entry 4 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,160.25 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 01, 2019 Filed Feb 14, 2020 21:15 UTC |
Hattem Dave S.SEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 1,458.1 | $20.20 | $29,453.62 |
DisclosureSEC source: 0001209191-20-009631 · doc5.xml · nonDerivative · entry 4 Hattem Dave S. · CIK 0001739394 · SEVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,984.85 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| March 01, 2019 Filed Feb 14, 2020 21:15 UTC |
Malmstrom AndersSenior EVP & CFO
|
Tax withholdingCommon Stock | 2,202.64 | $20.20 | $44,493.33 |
DisclosureSEC source: 0001209191-20-009628 · doc5.xml · nonDerivative · entry 4 Malmstrom Anders · CIK 0001705476 · Senior EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,748.94 F3 · shares: Shares withheld to cover taxes upon vesting of previous RSU grants. F2 · balance_after: Total includes RSUs. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:15 UTC |
Eckert William James IVSVP, CAO and Controller
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,179 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011286 · doc4.xml · derivative · entry 2 Eckert William James IV · CIK 0001693205 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,179 Underlying: Common Stock · 26,179 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:15 UTC |
Eckert William James IVSVP, CAO and Controller
|
GrantCommon Stock | 5,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011286 · doc4.xml · nonDerivative · entry 1 Eckert William James IV · CIK 0001693205 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,207 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC |
HURD JEFFREY JSenior EVP & COO
|
GrantEmployee Stock Option (right to buy) · Derivative | 117,802 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011279 · doc4.xml · derivative · entry 2 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,416 Underlying: Common Stock · 117,802 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC |
HURD JEFFREY JSenior EVP & COO
|
GrantCommon Stock | 24,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011279 · doc4.xml · nonDerivative · entry 1 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,270 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:08 UTC |
Lane Nick(See Remarks)
|
GrantEmployee Stock Option (right to buy) · Derivative | 124,346 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011278 · doc4.xml · derivative · entry 2 Lane Nick · CIK 0001441552 · (See Remarks) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,346 Underlying: Common Stock · 124,346 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:08 UTC |
Lane Nick(See Remarks)
|
GrantCommon Stock | 25,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011278 · doc4.xml · nonDerivative · entry 1 Lane Nick · CIK 0001441552 · (See Remarks) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,326 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:13 UTC |
BERNSTEIN SETH PSee Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 65,446 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011284 · doc4.xml · derivative · entry 2 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,446 Underlying: Common Stock · 65,446 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:13 UTC |
BERNSTEIN SETH PSee Remarks
|
GrantCommon Stock | 13,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011284 · doc4.xml · nonDerivative · entry 1 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,841 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:12 UTC |
Hattem Dave S.Senior EVP & GC
|
GrantEmployee Stock Option (right to buy) · Derivative | 65,446 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011282 · doc4.xml · derivative · entry 2 Hattem Dave S. · CIK 0001739394 · Senior EVP & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,676 Underlying: Common Stock · 65,446 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:12 UTC |
Hattem Dave S.Senior EVP & GC
|
GrantCommon Stock | 13,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011282 · doc4.xml · nonDerivative · entry 1 Hattem Dave S. · CIK 0001739394 · Senior EVP & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,873 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:11 UTC |
Malmstrom AndersSenior EVP & CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 117,802 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011281 · doc4.xml · derivative · entry 2 Malmstrom Anders · CIK 0001705476 · Senior EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,147 Underlying: Common Stock · 117,802 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:11 UTC |
Malmstrom AndersSenior EVP & CFO
|
GrantCommon Stock | 24,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011281 · doc4.xml · nonDerivative · entry 1 Malmstrom Anders · CIK 0001705476 · Senior EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,311 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:06 UTC |
Pearson MarkDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 359,948 | $0.00 Strike: $18.74 | $0.00 |
DisclosureSEC source: 0001209191-19-011276 · doc4.xml · derivative · entry 2 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,734 Underlying: Common Stock · 359,948 shares Expires 2029-02-14 F3 · derivative.exercise_date: Grant of employee stock option under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The option vests in three equal annual installments beginning on February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:06 UTC |
Pearson MarkDirector · President and CEO
|
GrantCommon Stock | 73,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011276 · doc4.xml · nonDerivative · entry 1 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,269 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three equal annual installments beginning on February 14, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 20:11 UTC |
Lane Nick(See Remarks)
|
GrantPerformance Restricted Stock Units · Derivative | 19,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007261 · doc4.xml · derivative · entry 2 Lane Nick · CIK 0001441552 · (See Remarks) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,978 Underlying: Common Stock · 19,978 shares Expires not disclosed F2 · derivative.exercise_price: Grant of performance restricted stock units (PRSUs) under the AXA Equitable Holdings, Inc. 2018 Omnibus Equity Incentive Plan exempt under Rule 16b-3. Each PRSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The PRSUs will vest upon and subject to achievement of the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 10, 2020, or (ii) if the PRSUs have not vested by May 10, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 10, 2023. If the PRSUs have not otherwise vested by May 10, 2023, 50% of the PRSUs will vest on May 10, 2023. F2 · derivative.exercise_date: Grant of performance restricted stock units (PRSUs) under the AXA Equitable Holdings, Inc. 2018 Omnibus Equity Incentive Plan exempt under Rule 16b-3. Each PRSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The PRSUs will vest upon and subject to achievement of the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 10, 2020, or (ii) if the PRSUs have not vested by May 10, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 10, 2023. If the PRSUs have not otherwise vested by May 10, 2023, 50% of the PRSUs will vest on May 10, 2023. F2 · derivative.expiration_date: Grant of performance restricted stock units (PRSUs) under the AXA Equitable Holdings, Inc. 2018 Omnibus Equity Incentive Plan exempt under Rule 16b-3. Each PRSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The PRSUs will vest upon and subject to achievement of the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 10, 2020, or (ii) if the PRSUs have not vested by May 10, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 10, 2023. If the PRSUs have not otherwise vested by May 10, 2023, 50% of the PRSUs will vest on May 10, 2023. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 20:11 UTC |
Lane Nick(See Remarks)
|
GrantCommon Stock | 19,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007261 · doc4.xml · nonDerivative · entry 1 Lane Nick · CIK 0001441552 · (See Remarks) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,979 F1 · shares: Grant of restricted stock units under the AXA Equitable Holdings, Inc. 2018 Omnibus Equity Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest according to the following schedule: 50% vest on the first anniversary of the grant date and 50% on the second anniversary of the grant date. Vested shares will be delivered to the reporting person within 30 days following the vesting date. Read SEC document |
| December 03, 2018 Filed Feb 14, 2020 21:15 UTC |
Eckert William James IVSVP and CAO
|
GrantCommon Stock | 58.21 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009632 · doc5.xml · nonDerivative · entry 1 Eckert William James IV · CIK 0001693205 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,259.21 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| December 03, 2018 Filed Feb 14, 2020 21:15 UTC |
HURD JEFFREY JSenior EVP & COO
|
GrantPerformance Restricted Stock Units · Derivative | 122.09 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009629 · doc5.xml · derivative · entry 11 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,726.65 Underlying: Common Stock · 122.09 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| December 03, 2018 Filed Feb 14, 2020 21:15 UTC |
HURD JEFFREY JSenior EVP & COO
|
GrantCommon Stock | 198.03 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009629 · doc5.xml · nonDerivative · entry 3 HURD JEFFREY J · CIK 0001486195 · Senior EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,529.63 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| December 03, 2018 Filed Feb 14, 2020 21:15 UTC |
BERNSTEIN SETH PSee Remarks
|
GrantPerformance Restricted Stock Units · Derivative | 122.09 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009630 · doc5.xml · derivative · entry 10 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,726.65 Underlying: Common Stock · 122.09 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F4 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
| December 03, 2018 Filed Feb 14, 2020 21:15 UTC |
BERNSTEIN SETH PSee Remarks
|
GrantCommon Stock | 61.04 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009630 · doc5.xml · nonDerivative · entry 3 BERNSTEIN SETH P · CIK 0001705584 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,055.33 F1 · shares: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock. F2 · balance_after: Total includes RSUs. Read SEC document |
| December 03, 2018 Filed Feb 14, 2020 21:15 UTC |
Pearson MarkDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 610.45 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009633 · doc5.xml · derivative · entry 11 Pearson Mark · CIK 0001512442 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,633.27 Underlying: Common Stock · 610.45 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F5 · shares: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. F5 · derivative.expiration_date: Dividend equivalents accrued on performance restricted stock units ("PRSUs") previously awarded pursuant to Issuer's incentive plan. Each PRSU represents a contingent right to receive one share of common stock upon vesting. The PRSUs vest upon and subject to the following criteria: (i) the Issuer's common stock achieving a market price of $26.00 for 30 consecutive days prior to May 14, 2020, or (ii) if the PRSUs have not vested by May 14, 2020, the Issuer's common stock achieving a market price of $30.00 for 30 consecutive days prior to May 14, 2023. If the PRSUs have not otherwise vested by May 14, 2023, 50% of the PRSUs will vest on May 14, 2023. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the PRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the related PRSUs. Dividend equivalents are issued as PRSUs, each representing a contingent right to receive one share of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.